Marc Bonneville, D.V.M. and CNRS research director, is currently in charge of the scientific and medical affairs at Institut Merieux, a biopharma company developing diagnostic and therapeutic tools in the field of infectious diseases, cancer and food safety. In 2016, he was appointed chairman of the Alliance for Research and Innovation in the Healthcare Industries (ARIIS). The purpose of this professional organization affiliated to the French Health Industry Federation (FEFIS) is to break down barriers in private research and promote synergies and partnerships between public research and industries in the field of Pharmaceuticals, Medical devices and diagnostics”.
Marc started to work in 1983 on transplantation immunology in Nantes (France), switched from 1987 to 1989 to analysis of mouse cellular immune responses during his postdoctoral training in S. Tonegawa’s laboratory (MIT, Boston), and has been heading an INSERM research team in Nantes from 1990, until he joined the Institut Merieux in 2013. He has been the director of an INSERM Research Center in Nantes (France) for more than 15 years.
Marc has authored more than 200 scientific papers, is co-inventor of 8 patents, and has been involved in more than 30 national and international scientific advisory boards and evaluation committees. He has received the CNRS silver medal and several prizes from charities (Fondation pour la Recherche Medicale, Ligue Nationale contre le Cancer, B. Halpern prize…) for his contributions in the field of human cellular immunity in the context of infections and cancer.
He was also a co-founder of Innate Pharma SA, a biotech company that implements new immunotherapies targeting innate lymphocytes in infectiology and oncology.
A new dimension in immuno-oncology
41 quai Fulchiron
69005 Lyon, FRANCE